124 related articles for article (PubMed ID: 37242534)
1. Assessment of Aptamer as a Potential Drug Targeted Delivery for Retinal Angiogenesis Inhibition.
Moreira D; Lopes-Nunes J; Santos FM; Campello MPC; Oliveira MC; Paulo A; Tomaz C; Cruz C
Pharmaceuticals (Basel); 2023 May; 16(5):. PubMed ID: 37242534
[TBL] [Abstract][Full Text] [Related]
2. Aptamer-guided acridine derivatives for cervical cancer.
Carvalho J; Lopes-Nunes J; Lopes AC; Cabral Campello MP; Paulo A; Queiroz JA; Cruz C
Org Biomol Chem; 2019 Mar; 17(11):2992-3002. PubMed ID: 30810582
[TBL] [Abstract][Full Text] [Related]
3. G-Quadruplex Aptamer-Ligand Characterization.
Moreira D; Leitão D; Lopes-Nunes J; Santos T; Figueiredo J; Miranda A; Alexandre D; Tomaz C; Mergny JL; Cruz C
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296374
[TBL] [Abstract][Full Text] [Related]
4. Stabilization of a DNA aptamer by ligand binding.
Santos T; Lopes-Nunes J; Alexandre D; Miranda A; Figueiredo J; Silva MS; Mergny JL; Cruz C
Biochimie; 2022 Sep; 200():8-18. PubMed ID: 35550917
[TBL] [Abstract][Full Text] [Related]
5. Phthalocyanines for G-quadruplex aptamers binding.
Lopes-Nunes J; Carvalho J; Figueiredo J; Ramos CIV; Lourenço LMO; Tomé JPC; Neves MGPMS; Mergny JL; Queiroz JA; Salgado GF; Cruz C
Bioorg Chem; 2020 Jul; 100():103920. PubMed ID: 32413624
[TBL] [Abstract][Full Text] [Related]
6. Locking up the AS1411 Aptamer with a Flanking Duplex: Towards an Improved Nucleolin-Targeting.
Miranda A; Santos T; Largy E; Cruz C
Pharmaceuticals (Basel); 2021 Feb; 14(2):. PubMed ID: 33557379
[TBL] [Abstract][Full Text] [Related]
7. Gallic Acid-Triethylene Glycol Aptadendrimers Synthesis, Biophysical Characterization and Cellular Evaluation.
Miranda A; Lopez-Blanco R; Lopes-Nunes J; Melo AM; Campello MPC; Paulo A; Oliveira MC; Mergny JL; Oliveira PA; Fernandez-Megia E; Cruz C
Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36432647
[TBL] [Abstract][Full Text] [Related]
8. RNA G-quadruplex as supramolecular carrier for cancer-selective delivery.
Santos T; Pereira P; Campello MPC; Paulo A; Queiroz JA; Cabrita E; Cruz C
Eur J Pharm Biopharm; 2019 Sep; 142():473-479. PubMed ID: 31325486
[TBL] [Abstract][Full Text] [Related]
9. Biological studies of an ICG-tagged aptamer as drug delivery system for malignant melanoma.
Lopes-Nunes J; Lifante J; Shen Y; Ximendes EC; Jaque D; Iglesias-de la Cruz MC; Cruz C
Eur J Pharm Biopharm; 2020 Sep; 154():228-235. PubMed ID: 32707287
[TBL] [Abstract][Full Text] [Related]
10. Aptamer-based Targeted Delivery of a G-quadruplex Ligand in Cervical Cancer Cells.
Carvalho J; Paiva A; Cabral Campello MP; Paulo A; Mergny JL; Salgado GF; Queiroz JA; Cruz C
Sci Rep; 2019 May; 9(1):7945. PubMed ID: 31138870
[TBL] [Abstract][Full Text] [Related]
11. RNA-based liposomes for oral cancer: From biophysical characterization to biological evaluation.
Lopes-Nunes J; Simões P; Moreira D; Leandro K; Nobre RJ; Pereira de Almeida L; Campello MPC; Oliveira MC; Paulo A; Coutinho A; Melo AM; Tomaz C; Cruz C
Int J Biol Macromol; 2024 Feb; 259(Pt 2):129157. PubMed ID: 38199539
[TBL] [Abstract][Full Text] [Related]
12. AS1411-functionalized delivery nanosystems for targeted cancer therapy.
Kozani PS; Kozani PS; Malik MT
Explor Med; 2021; 2():146-166. PubMed ID: 34723284
[TBL] [Abstract][Full Text] [Related]
13. AS1411 Nucleolin-Specific Binding Aptamers Reduce Pathological Angiogenesis through Inhibition of Nucleolin Phosphorylation.
Iturriaga-Goyon E; Vivanco-Rojas O; Magaña-Guerrero FS; Buentello-Volante B; Castro-Salas I; Aguayo-Flores JE; Gracia-Mora I; Rivera-Huerta M; Sánchez-Bartés F; Garfias Y
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884955
[TBL] [Abstract][Full Text] [Related]
14. AS1411 derivatives as carriers of G-quadruplex ligands for cervical cancer cells.
Figueiredo J; Lopes-Nunes J; Carvalho J; Antunes F; Ribeiro M; Campello MPC; Paulo A; Paiva A; Salgado GF; Queiroz JA; Mergny JL; Cruz C
Int J Pharm; 2019 Sep; 568():118511. PubMed ID: 31301466
[TBL] [Abstract][Full Text] [Related]
15. Selective Delivery of an Anticancer Drug with Aptamer-Functionalized Liposomes to Breast Cancer Cells
Xing H; Tang L; Yang X; Hwang K; Wang W; Yin Q; Wong NY; Dobrucki LW; Yasui N; Katzenellenbogen JA; Helferich WG; Cheng J; Lu Y
J Mater Chem B; 2013 Oct; 1(39):5288-5297. PubMed ID: 24159374
[TBL] [Abstract][Full Text] [Related]
16. Aptamer-functionalized quercetin thermosensitive liposomes for targeting drug delivery and antitumor therapy.
Li J; Gao Y; Liu S; Cai J; Zhang Q; Li K; Liu Z; Shi M; Wang J; Cui H
Biomed Mater; 2022 Sep; 17(6):. PubMed ID: 36001994
[TBL] [Abstract][Full Text] [Related]
17. Aptamer-based approaches to detect nucleolin in prostate cancer.
Miranda A; Santos T; Carvalho J; Alexandre D; Jardim A; Caneira CF; Vaz V; Pereira B; Godinho R; Brito D; Chu V; Conde JP; Cruz C
Talanta; 2021 May; 226():122037. PubMed ID: 33676639
[TBL] [Abstract][Full Text] [Related]
18. A Non-G-Quadruplex DNA Aptamer Targeting NCL for Diagnosis and Therapy in Bladder Cancer.
Liu Y; Hu B; Pei X; Li J; Qi D; Xu Y; Ou H; Wu Y; Xue L; Huang JH; Wu E; Hu X
Adv Healthc Mater; 2023 Aug; 12(20):e2300791. PubMed ID: 37262080
[TBL] [Abstract][Full Text] [Related]
19. AS1411 aptamer-functionalized exosomes in the targeted delivery of doxorubicin in fighting colorectal cancer.
Hosseini NF; Amini R; Ramezani M; Saidijam M; Hashemi SM; Najafi R
Biomed Pharmacother; 2022 Nov; 155():113690. PubMed ID: 36099793
[TBL] [Abstract][Full Text] [Related]
20. Bifunctional G-Quadruplex Aptamer Targeting Nucleolin and Topoisomerase 1: Antiproliferative Activity and Synergistic Effect of Conjugated Drugs.
Jo J; Bae S; Jeon J; Youn H; Lee G; Ban C
Bioconjug Chem; 2023 Jan; 34(1):238-247. PubMed ID: 36516871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
